0
By clicking the button, I accept the Terms of Use of the service and its Privacy Policy, as well as consent to the processing of personal data.
Don’t have an account? Signup
Tvaster will use the fresh investment to accelerate the expansion and commercialisation of Episcreen Liver, a pioneering methylation-based liquid biopsy test for early liver cancer detection.
Share this article
If you liked this article share it with your friends.they will thank you later